{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:06:41Z","timestamp":1791292001556,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.parkreldis.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T16:44:05Z","timestamp":1312649045000},"page":"730-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson\u2019s disease susceptibility?"],"prefix":"10.1016","volume":"17","author":[{"given":"Joanna M.","family":"Biernacka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.","family":"Armasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Eric Ahlskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrius M.","family":"Maraganore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.parkreldis.2011.07.001_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00439-008-0582-9","article-title":"Genomewide association study for susceptibility genes contributing to familial Parkinson disease","volume":"124","author":"Pankratz","year":"2009","journal-title":"Hum Genet"},{"issue":"12","key":"10.1016\/j.parkreldis.2011.07.001_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.parkreldis.2011.07.001_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.parkreldis.2011.07.001_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann Hum Genet"},{"issue":"5321","key":"10.1016\/j.parkreldis.2011.07.001_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.parkreldis.2011.07.001_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"5646","key":"10.1016\/j.parkreldis.2011.07.001_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.parkreldis.2011.07.001_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease","volume":"296","author":"Maraganore","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.parkreldis.2011.07.001_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.1228","article-title":"Case-control study of the extended tau gene haplotype in Parkinson\u2019s disease","volume":"50","author":"Maraganore","year":"2001","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2011.07.001_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/[alpha]-synuclein-epitopes in Lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2990.2007.00888.x","article-title":"LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson\u2019s disease","volume":"34","author":"Alegre-Abarrategui","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5619","key":"10.1016\/j.parkreldis.2011.07.001_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","article-title":"[alpha]-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton","volume":"26","author":"Esposito","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1016\/j.parkreldis.2011.07.001_bib14","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: Relevance to Parkinson\u2019s disease","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bies.200900163","article-title":"Mechanisms in dominant parkinsonism: the toxic triangle of LRRK2, \u03b1-synuclein, and tau","volume":"32","author":"Taymans","year":"2010","journal-title":"BioEssays"},{"issue":"5","key":"10.1016\/j.parkreldis.2011.07.001_bib16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cellsig.2010.01.006","article-title":"Leucine-rich repeat kinase 2 induces [alpha]-synuclein expression via the extracellular signal-regulated kinase pathway","volume":"22","author":"Carballo-Carbajal","year":"2010","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.parkreldis.2011.07.001_bib17","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jnr.21622","article-title":"The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules","volume":"86","author":"Gandhi","year":"2008","journal-title":"J\u00a0Neurosci Res"},{"issue":"21","key":"10.1016\/j.parkreldis.2011.07.001_bib18","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic interactions between A{beta}, tau, and {alpha}-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.parkreldis.2011.07.001_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch Neurol"},{"issue":"16 Pt 2","key":"10.1016\/j.parkreldis.2011.07.001_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/01.wnl.0000304049.31377.f2","article-title":"Alpha-synuclein, pesticides, and Parkinson disease: a case-control study","volume":"70","author":"Brighina","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2011.07.001_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.23376","article-title":"Common variants in PARK loci and related genes and Parkinson\u2019s disease","volume":"26","author":"Chung","year":"2011","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2011.07.001_bib22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","article-title":"Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976\u20131990","volume":"52","author":"Bower","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2011.07.001_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0895-4356(98)00017-1","article-title":"Validation of a telephone questionnaire for Parkinson\u2019s disease","volume":"51","author":"Rocca","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gepi.20300","article-title":"Increasing the power of identifying gene\u00a0\u00d7 gene interactions in genome-wide association studies","volume":"32","author":"Kooperberg","year":"2008","journal-title":"Genet Epidemiol"},{"issue":"2","key":"10.1016\/j.parkreldis.2011.07.001_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.parkreldis.2011.07.001_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson\u2019s disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ana.20387","article-title":"Interaction of alpha-synuclein and tau genotypes in Parkinson\u2019s disease","volume":"57","author":"Mamah","year":"2005","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2011.07.001_bib28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mds.10431","article-title":"Complex interactions in Parkinson\u2019s disease: a two-phased approach","volume":"18","author":"Maraganore","year":"2003","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00439-008-0466-z","article-title":"Exploring gene-environment interactions in Parkinson\u2019s disease","volume":"123","author":"McCulloch","year":"2008","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.07.001_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10048-009-0170-8","article-title":"Whole-genome conditional two-locus analysis identifies novel candidate\u00a0genes for late-onset Parkinson\u2019s disease","volume":"10","author":"Gonzalez-Perez","year":"2009","journal-title":"Neurogenetics"},{"issue":"5","key":"10.1016\/j.parkreldis.2011.07.001_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/aje\/155.5.478","article-title":"Sample size requirements for association studies of gene\u2013gene interaction","volume":"155","author":"Gauderman","year":"2002","journal-title":"Am J Epidemiol"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:12:42Z","timestamp":1761178362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802011002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1353802011002197"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.07.001","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson\u2019s disease susceptibility?","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}